Speeches

Read speeches, public addresses and congressional testimony by PhRMA CEO and President John Castellani and other pharmaceutical industry leaders. Click on any of the links below to read one of the speeches.

Letter to the Centers for Medicare and Medicaid Services (CMS) from PhRMA, AdvaMed, and BIO

Week In Review: When Minor Discoveries Make All The Difference

04.06.13 | By

Have you ever considered what it took to develop medicines, like aspirin, that we use regularly? It was far from an overnight discovery. The medicines we sometimes take for granted are the result of decades of intense research and development.

Press Room

PhRMApedia's Press Room provides the most recent press releases. Search PhRMApedia for additional press releases.

Incremental Innovation: Personalized Medicine Coalition Concludes our Series

04.05.13 | By

What a great week on the Catalyst! We heard several different perspectives on incremental innovation and the value that medicines provide to millions of patients suffering from disease.

Incremental Innovation Series: IFPMA and Biopharmaceutical Progress

04.05.13 | By

A recent report from the IFPMA (the International Federation of Pharmaceutical Manufacturers and Associations) adds to the growing body of work on the cumulative, step-wise nature of biopharmaceutical progress, with a particular focus on incremental innovation.

The National Hurricane Conference - Dialogue and Lessons Learned

04.05.13 | By

Last week at the National Hurricane Conference, Rx Response announced a new, easier-to-remember name and website for its much-praised pharmacy status reporting tool - Rx Open .

PhRMA Code on Interactions - Annual Certifications

PhRMA Code on Interactions - Signatory Companies

Dementia Report Wake-up Call

04.04.13 | By

If you're not worried by dementia - its personal cost and its economic toll - you should be. I am. Anyone who, like me, has had a family member die with dementia understands the devastation: the years - if not decades - of the living loss of a loved one; the drain on family and healthcare resources; the unmet hope that something may be done to relieve or reverse the insidious progress of the condition.

Incremental Innovation Series: Focus on Rheumatoid Arthritis

04.03.13 | By

As part of our ongoing incremental innovation series on the Catalyst, Thomas F. Goss, PharmD, Senior Vice President, Boston Healthcare Associates, highlights the importance of medical progress for patients suffering from rheumatoid arthritis in his very own blog post: The weather is warming (finally) here in the northeast, and like many families, we found ourselves enjoying the warm outdoor weather this past weekend.

Pages

Subscribe to RSS - Opinion